Department of Pulmonary, Allergy and Critical Care Medicine, Respiratory Institute, Cleveland, OH.
Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH.
Chest. 2012 Jun;141(6):1457-1465. doi: 10.1378/chest.11-1903. Epub 2011 Dec 29.
Little is known about the association between left ventricular (LV) diastolic dysfunction and outcomes in patients with idiopathic or heritable pulmonary arterial hypertension (PAH). Our rationale was to investigate the prevalence of LV diastolic dysfunction, and its association with disease severity and outcomes, in patients with idiopathic or heritable PAH.
Using the Cleveland Clinic Pulmonary Hypertension Registry, we identified subjects with heritable or idiopathic PAH who underwent Doppler echocardiography and right-sided heart catheterization. Echocardiographic diastolic parameters were assessed in each patient.
A total of 61 patients met the inclusion criteria (idiopathic 85%, heritable 15%). The age at the time of echocardiography was 48.3 ± 18 years, 84% of the subjects were women, and 48% were on PAH-targeted therapies. Normal LV diastolic function, impaired relaxation, and pseudonormalization were seen in 10%, 88%, and 2% of the patients, respectively. Peak early diastolic (peak E) velocity was directly associated with LV end-diastolic volume and cardiac index and inversely associated with the degree of right ventricular dilation, right atrial pressure, and pulmonary vascular resistance. Peak E velocity was associated with mortality adjusted for age and sex (hazard ratio [HR], 1.5; 95% CI, 1.1-2 per 10 cm/s decrease; P = .015) and age, sex, 6-min walk distance, and cardiac output (HR, 1.8; 95% CI, 1.2-2.9 per 10 cm/s decrease; P = .01).
LV diastolic dysfunction of the impaired relaxation type is observed in the majority of patients with advanced idiopathic or heritable PAH. A decrease in transmitral flow peak E velocity is associated with worse hemodynamics and outcome.
左心室(LV)舒张功能障碍与特发性或遗传性肺动脉高压(PAH)患者的结局之间的关系鲜为人知。我们的基本原理是研究特发性或遗传性 PAH 患者中 LV 舒张功能障碍的发生率及其与疾病严重程度和结局的关系。
我们使用克利夫兰诊所肺动脉高压注册中心,确定了接受多普勒超声心动图和右心导管检查的遗传性或特发性 PAH 患者。对每位患者进行超声心动图舒张参数评估。
共有 61 名患者符合纳入标准(特发性占 85%,遗传性占 15%)。超声心动图时的年龄为 48.3±18 岁,84%的患者为女性,48%接受 PAH 靶向治疗。分别有 10%、88%和 2%的患者出现正常 LV 舒张功能、松弛受损和假性正常化。舒张早期峰值速度(peak E)与 LV 舒张末期容积和心指数直接相关,与右心室扩张程度、右心房压和肺血管阻力呈反比。在调整年龄和性别后,peak E 速度与死亡率相关(危险比 [HR],每降低 10cm/s 增加 1.5;95%置信区间 [CI],1.1-2.0;P=0.015),并与年龄、性别、6 分钟步行距离和心输出量相关(HR,每降低 10cm/s 增加 1.8;95%CI,1.2-2.9;P=0.01)。
大多数晚期特发性或遗传性 PAH 患者存在舒张功能障碍的松弛受损型。经二尖瓣血流峰值 E 速度降低与血流动力学恶化和结局不良相关。